TABLE 2.
Patient group and no. | Intrahepatic HBV DNA level (no. of copies/ng of hgDNA) | Serum HBV DNA level (log10 copies/ml) | ALT concn (U/liter) | Necroinflammation statusa | Fibrosis statusa |
---|---|---|---|---|---|
HBeAg positive | |||||
1 | 511 | 7.82 | 74 | Minimal | Mild |
2 | 1,800 | 6.62 | 53 | Mild | Moderate |
3 | 2,360 | 8.26 | 175 | Minimal | Cirrhosis |
4 | 4,210 | 8.76 | 71 | Mild | Moderate |
5 | 4,310 | 7.05 | 43 | Mild | Mild |
6 | 5,460 | 8.49 | 124 | Mild | Moderate |
7 | 6,790 | 9.37 | 38 | Mild | Mild |
8 | 6,950 | 7.21 | 212 | Mild | Moderate |
9 | 9,460 | 8.75 | 57 | Mild | Moderate |
10 | 10,700 | 8.71 | 70 | Mild | Mild |
11 | 12,700 | 6.27 | 85 | Mild | Mild |
12 | 15,100 | 7.25 | 72 | Mild | Moderate |
13 | 21,300 | 8.94 | 83 | Mild | Moderate |
14 | 22,700 | 8.00 | 357 | Mild | Moderate |
15 | 55,500 | 9.56 | 95 | Minimal | Moderate |
Anti-HBe positive | |||||
16 | 0.158 | 4.07 | 21 | Minimal | None |
17 | 0.31 | <2.30b | 28 | Minimal | Mild |
18 | 1.14 | 4.29 | 38 | Minimal | None |
19 | 3.31 | 5.26 | 22 | Minimal | None |
20 | 5.10 | 4.57 | 25 | Minimal | None |
21 | 43.6 | 5.99 | 190 | Mild | Moderate |
22 | 79.2 | 3.22 | 28 | Mild | Mild |
23 | 101 | 4.71 | 32 | Minimal | None |
24 | 166 | 6.67 | 130 | Mild | Moderate |
25 | 254 | 6.79 | 41 | Mild | Moderate |
26 | 404 | 7.19 | 73 | Minimal | Moderate |
27 | 585 | 6.25 | 51 | Moderate | Moderate |
28 | 610 | 7.11 | 170 | Mild | Mild |
29 | 742 | 6.54 | 43 | Moderate | Moderate |
30 | 782 | 6.73 | 275 | Minimal | Mild |
31 | 1,050 | 7.70 | 216 | Moderate | Mild |
32 | 1,200 | 7.31 | 76 | Moderate | Moderate |
33 | 1,510 | 7.26 | 67 | Mild | Moderate |
34 | 2,230 | 7.10 | 85 | Mild | Moderate |
35 | 2,410 | 6.85 | 223 | Minimal | None |
36 | 3,250 | 9.16 | 154 | Minimal | Cirrhosis |
37 | 3,310 | 7.23 | 70 | Mild | Moderate |
38 | 5,120 | 6.86 | 153 | Mild | Moderate |
39 | 5,250 | 8.11 | 87 | Minimal | Moderate |
40 | 5,360 | 7.54 | 248 | Moderate | Moderate |
41 | 7,310 | 7.58 | 134 | Minimal | Moderate |
The histologic classification are described in the Materials and Methods section.
Undetectable.